Rabeprazole Sodium 20 mg / 1 Tablet 250 Tablet, Delayed Release

Reference details for licensed healthcare facility review and verification.

NDC 1162175-0302-42
Product NDC62175-0302
Generic Drug NameRabeprazole Sodium
Brand NameRabeprazole Sodium
ManufacturerLannett Company, Inc.
Strength20 mg / 1
Dosage FormTablet
Drug TypeOral
Package Quantity250 Tablet, Delayed Release
Package Description250 TABLET, DELAYED RELEASE in 1 BOTTLE (62175-302-42)
Active IngredientsRabeprazole Sodium
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Rabeprazole Sodium 20 mg / 1 Tablet is tracked under NDC 62175-0302-42 and rolls up into product family 62175-0302. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 250 Tablet, Delayed Release.
  • Manufacturer: Lannett Company, Inc..
  • Dosage form: Tablet.
  • Family size: 5 indexed presentations.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Rabeprazole Sodium 20 mg / 1 Tablet 250 Tablet, Delayed Release, NDC 62175-0302-42, is a Lannett Company, Inc. 20 mg / 1 tablet presentation packaged as 250 Tablet, Delayed Release.

NDC search formats

  • Canonical NDC 11: 62175-0302-42
  • Digits-only NDC 11: 62175030242
  • Possible 10-digit display format: 62175-302-42 (6217530242)

Helpful product links